About Marius Pharmaceuticals
Marius Pharmaceuticals is a company based in Raleigh (United States) founded in 2017 by Himanshu H Shah and Om Dhingra. It operates as a Direct-to-Consumer (D2C). Marius Pharmaceuticals has raised $11.61 million across 2 funding rounds. Marius Pharmaceuticals offers products and services including KYZATREX. Marius Pharmaceuticals operates in a competitive market with competitors including Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech, Agile Therapeutics and Asarina Pharma, among others.
- Headquarter Raleigh, United States
- Founders Himanshu H Shah, Om Dhingra
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Marius Pharmaceuticals
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.61 M (USD)
in 2 rounds
-
Latest Funding Round
$6.01 M (USD), Series B
Oct 05, 2021
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Marius Pharmaceuticals
Marius Pharmaceuticals offers a comprehensive portfolio of products and services, including KYZATREX.
Oral testosterone therapy for men with deficiency issues.
People of Marius Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Marius Pharmaceuticals
Marius Pharmaceuticals has successfully raised a total of $11.61M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $6.01 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Marius Pharmaceuticals
Investment portfolio details for Marius Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Marius Pharmaceuticals
Detailed financials for Marius Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Marius Pharmaceuticals Comparisons
Peer comparison for Marius Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Marius Pharmaceuticals
Marius Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech, Agile Therapeutics and Asarina Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of therapeutics and drug-device combinations for urology and sexual health
|
|
| Locked | Locked | Locked |
Developer of drugs for women's health and pain management
|
|
| Locked | Locked | Locked |
Microchip implants for wireless drug delivery are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's healthcare are developed and offered.
|
|
| Locked | Locked | Locked |
Pharmaceuticals for PMDD, migraine, and Tourette syndrome are developed.
|
Detailed competitors of Marius Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Marius Pharmaceuticals
Complete news archive for Marius Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marius Pharmaceuticals
Marius Pharmaceuticals was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Marius Pharmaceuticals is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Shalin Y Shah is the current CEO of Marius Pharmaceuticals.
Marius Pharmaceuticals is a funded company, having raised a total of $11.61M across 2 funding rounds to date.
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies. The company addresses testosterone deficiency, impacting metabolic vitality and well-being for both men and women. Solutions are developed to improve conditions like obesity, type 2 diabetes, and menopausal symptoms in women. Research initiatives are supported to explore hormone imbalances across various comorbidities and patient populations. Innovative oral testosterone therapy, such as KYZATREX, is provided to treat adult men with low testosterone levels due to specific medical conditions.
Marius Pharmaceuticals's top competitors include Agile Therapeutics, Auxilium Pharmaceuticals and Peptonic Medical.
Marius Pharmaceuticals offers KYZATREX.